Table 3.
Variables | Acute Group No. (%) Or Median | Chronic Group No. (%) Or Median | P-value |
---|---|---|---|
Technical success | 63 (100) | 23 (100) | |
Follow-up, months | 34(26) | 36(30) | |
30-day mortality | 0 | 1 (4.3) | 0.267 |
30-day aortic-related mortality | 0 | 1 (4.3) | 0.267 |
>30-day mortality | 2 (3.2) | 2 (9.1) | 0.587 |
>30-day aortic-related mortality | 1 (1.6) | 1 (4.5) | 0.453 |
Aortic rupture | 0 | 2 (8.7) | 0.069 |
Endoleak | 4 (6.3) | 2 (8.7) | 0.576 |
Distal SINE | 2 (3.2) | 1 (4.3) | 1 |
RTAD | 1 (1.6) | 0 | 1 |
Distal stent collapse | 0 | 3 (13.04) | 0.017 |
Stroke | 3 (4.8) | 1 (4.3) | 1 |
Spinal ischemia or paraplegia | 2 (3.2) | 1 (4.3) | 1 |
Renal failure | 4 (6.3) | 3 (13.0) | 0.576 |
Secondary intervention | 2 (3.2) | 1 (4.3) | 1 |
Abbreviations: SINE, stent graft-induced new entry; RTAD, retrograde type A dissection.